Gossamer Bio (GOSS) Invested Capital (2022 - 2026)

Gossamer Bio's Invested Capital history runs 3 years deep, the most recent figure standing at $9.6 million for Q1 2024.

• In Q1 2024, Invested Capital fell 17.43% year-over-year to $9.6 million; the TTM figure through Dec 2024 stood at $9.6 million (down 79.36% YoY), while the FY2023 annual figure was $11.6 million, changed 0.0% from the prior year.
• Invested Capital for Q1 2024 stood at $9.6 million, down from $11.6 million in the prior quarter.
• The five-year high for Invested Capital was $11.6 million in Q4 2022, with the low at $9.6 million in Q1 2024.
• The 3-year median for Invested Capital is $11.6 million (2022), against an average of $11.3 million.
• The sharpest annual moves came in 2023 and 2024: Invested Capital changed 0.0% in 2023, then retreated 17.43% in 2024.
• Gossamer Bio's Invested Capital stood at $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then decreased by 17.43% to $9.6 million in 2024.
• Business Quant data shows GOSS's Invested Capital at $9.6 million in Q1 2024, $11.6 million in Q4 2023, and $11.6 million in Q3 2023.